← Browse by Condition
Medical Condition

anticoagulant

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT04257487 Phase 3
Recruiting

Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)

Enrollment
1,455 pts
Location
Italy
Sponsor
Arianna Anticoagulazione Found...
View Trial →